Expression of CD81 and CD117 in Plasma Cell Myeloma and the Relationship to Prognosis

Cancer Medicine - United Kingdom
doi 10.1002/cam4.1840
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Prognosis Value of RBBP8 Expression in Plasma Cell Myeloma

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2019English

Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2016English

Expression of THOP1 and Its Relationship to Prognosis in Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2014English

Plasma Cell Satellitism in Plasma Cell Myeloma

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Rare KIT (CD117) Expression in Multiple Myeloma Abrogates the Usefulness of Imatinib Mesylate Treatment

Virchows Archiv
MedicineForensic MedicinePathologyCell BiologyMolecular Biology
2004English

Increased Circulating Plasma Cells Detected by Flow Cytometry Predicts Poor Prognosis in Patients With Plasma Cell Myeloma

Cytometry Part B - Clinical Cytometry
Forensic MedicinePathologyHistologyCell Biology
2017English

High Expression of UBE2T Predicts Poor Prognosis and Survival in Multiple Myeloma

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2019English

Myeloma Therapy: Pursuing the Plasma Cell

British Journal of Cancer
Cancer ResearchOncology
2010English

Enhanced Expression of FCER1G Predicts Positive Prognosis in Multiple Myeloma

Journal of Cancer
Oncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy